Evaluierung neuer nephroprotektiver Strategien in einem Mausmodell der strahleninduzierten Nephropathie durch den ß-Emitter [Lu-177-DOTA0,TYR3]-octreotate mittels in-vivo Tc-99m-MAG3 Nierenfunktionsszintigraphie

Evaluierung neuer nephroprotektiver Strategien in einem Mausmodell der strahleninduzierten Nephropathie durch den ß-Emitter [Lu-177-DOTA0,TYR3]-octreotate mittels in-vivo Tc-99m-MAG3 Nierenfunktionsszintigraphie

Bibliographic Details
Main Author:	Ilhan, Harun
Format:	Others
Published:	Ludwig-Maximilians-Universität München 2013
Subjects:	Medizinische Fakultät
Online Access:	http://edoc.ub.uni-muenchen.de/16593/1/Ilhan_Harun.pdf http://nbn-resolving.de/urn:nbn:de:bvb:19-165939

Similar Items

Implementation of patient dosimetry in the clinical practice after targeted radiotherapy using [177Lu-[DOTA0, Tyr3]-octreotate
by: Lore Santoro, et al.
Published: (2018-11-01)

Phase I study of the 177Lu-DOTA0-Tyr3-Octreotate (lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lung
by: Giuseppe Esposito, et al.
Published: (2020-07-01)

Cellular dosimetry of [177Lu]Lu-DOTA-[Tyr3]octreotate radionuclide therapy: the impact of modeling assumptions on the correlation with in vitro cytotoxicity
by: Giulia Tamborino, et al.
Published: (2020-02-01)

In Vivo Measurement and Characterization of a Novel Formulation of [177Lu]-DOTA-Octreotate
by: Dale Bailey, et al.
Published: (2016-01-01)

Terapia com [177Lu – Dota0 – Tyr3]–Octreotate (177Lu-Dotatate) em Pacientes com Tumores Avançados de Origem Neuroendócrino: Experiência Inicial e Resultados Preliminares
by: Víctor Marín Oyaga, et al.
Published: (2017-10-01)

Patient-specific image-based bone marrow dosimetry in Lu-177-[DOTA0,Tyr3]-Octreotate and Lu-177-DKFZ-PSMA-617 therapy: investigation of a new hybrid image approach
by: Astrid Gosewisch, et al.
Published: (2018-08-01)

177Lu-DOTA-octreotate Radionuclide Therapy of Neuroendocrine Tumours : Dosimetry-Based Therapy Planning and Outcome
by: Garske-Román, Ulrike
Published: (2012)

Histologische und molekulargenetische Untersuchungen von strahleninduzierten Schilddrüsentumoren im Mausmodell
by: Hölzlwimmer, Gabriele
Published: (2007)

Electrochemical separation of 90-yttrium in the electrochemical 90Sr/90Y generator and its use for radiolabelling of DOTA-conjugated somatostatin analog [DOTA0, Tyr3] octreotate
by: Petrović Đorđe Ž., et al.
Published: (2012-01-01)

Dosimetry of Radionuclide Therapy with 177Lu-octreotate
by: Sandström, Mattias
Published: (2011)

Salvage PRRT with 177Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival
by: S. Rudisile, et al.
Published: (2019-08-01)

Chemotherapy-Induced Upregulation of Somatostatin Receptor-2 Increases the Uptake and Efficacy of <sup>177</sup>Lu-DOTA-Octreotate in Neuroendocrine Tumor Cells
by: Rashmi G. Shah, et al.
Published: (2021-01-01)

Charakterisierung eines Mausmodells für die Evaluierung neuer Mitglieder der CEA-Familie als mögliche Zielstrukturen für die Tumortherapie
by: Zebhauser, Roland Andreas
Published: (2006)

Cinética e dosimetria do [177Lu-DOTA0, Tyr3]octreotato em pacientes com tumores carcinoides
by: Ana Claudia Machado Silva
Published: (2014)

Cinética e dosimetria do [177Lu-DOTA0, Tyr3]octreotato em pacientes com tumores carcinoides
by: Silva, Ana Claudia Machado
Published: (2014)

Neuroblastoma xenograft models demonstrate the therapeutic potential of 177Lu-octreotate
by: Arman Romiani, et al.
Published: (2021-08-01)

Značení DOTA-Tyr(3) - oktreotáru oxidativní jodací
by: Tvrdíková, Klára
Published: (2007)

Lessons on Tumour Response: Imaging during Therapy with 177Lu-DOTA-octreotate. A Case Report on a Patient with a Large Volume of Poorly Differentiated Neuroendocrine Carcinoma
by: Ulrike Garske, Mattias Sandström, Silvia Johansson, Dan Granberg, Hans Lundqvist, Mark Lubberink, Anders Sundin, Barbro Eriksson
Published: (2012-01-01)

Accuracy and reproducibility of simplified QSPECT dosimetry for personalized 177Lu-octreotate PRRT
by: Michela Del Prete, et al.
Published: (2018-10-01)

Neuroendocrine prostate cancer or prostatitis? An unusual false positive on gallium-68 DOTA-Tyr3-octreotate positron emission tomography/computed tomography in a patient with known metastatic neuroendocrine tumor
by: Matthew Q Schmidt, et al.
Published: (2019-01-01)

Epidemiologie des strahleninduzierten Mammakarzinoms
by: Nekolla, Elke
Published: (2004)

Intra-arterial versus standard intravenous administration of lutetium-177-DOTA-octreotate in patients with NET liver metastases: study protocol for a multicenter, randomized controlled trial (LUTIA trial)
by: Sander C. Ebbers, et al.
Published: (2020-02-01)

Cinética e dosimetria do [sup(177)LU-DOTA sup(0), TYR sup(3)]octreotato em pacientes com tumores carcinoides
by: SILVA, ANA C.M.
Published: (2014)

Cinética e dosimetria do [sup(177)LU-DOTA sup(0), TYR sup(3)]octreotato em pacientes com tumores carcinoides
by: SILVA, ANA C.M.
Published: (2014)

Entwicklung und Evaluierung neuer Bioreaktorkonzepte für phototrophe Mikroorganismen
by: Krujatz, Felix
Published: (2016)

Potential Biomarkers for Radiation-Induced Renal Toxicity following 177Lu-Octreotate Administration in Mice.
by: Emil Schüler, et al.
Published: (2015-01-01)

Comparison of68Ga-DOTA-NaI3-Octreotide/tyr3-octreotate positron emission tomography/computed tomography and contrast-enhanced computed tomography in localization of tumors in multiple endocrine neoplasia 1 syndrome
by: Virendra A Patil, et al.
Published: (2020-01-01)

Adenovirus Serotype 5 Vectors with Tyr3-Octreotate Modified as a Virulytic Oncotherapy Agent in AGS Cells
by: Najmeh Yarkeh Salkhori, et al.
Published: (2020-12-01)

Charakterisierung der in vivo Wachstumskinetik amyloider Plaques und der synaptischen Pathologie mit Evaluierung eines immuntherapeutischen Ansatzes in einem Alzheimer-Mausmodell
by: Burgold, Steffen
Published: (2013)

Positron Emission Tomographic Imaging of Copper 64– and Gallium 68–Labeled Chelator Conjugates of the Somatostatin Agonist Tyr-Octreotate
by: Jessie R. Nedrow, et al.
Published: (2014-09-01)

Evaluierung bestehender Prüfungsmodalitäten in der Zahnärztlichen Vorprüfung und Implementierung neuer Prüfungsstrukturen
by: Ellerbrock, Maike
Published: (2019)

Studium stability monoklonální protilátky nimotuzumab modifikované chelátorem DOTA radioaktivně značené luteciem-177 ([177Lu]Lu-hR3(p-SCN-Bn)DOTA)
by: Petřík, Michal
Published: (2010)

Direct Synthesis of DOTA-Tyr3-Octreotide Using Solid Phase Peptide Synthesis
by: Shu-Ling Chen, et al.
Published: (2004)

Distinct microRNA expression profiles in mouse renal cortical tissue after 177Lu-octreotate administration.
by: Emil Schüler, et al.
Published: (2014-01-01)

Entwicklung neuer Strategien zur Überwindung transporter-basierter Pharmakoresistenz bei Epilepsien
by: Czapp, Marion
Published: (2007)

Vergleichende Analyse der Reparatur von strahleninduzierten DNA-Schäden und der strahleninduzierten Apoptose in Lymphozyten junger Lungentumorpatienten und gesunder Kontrollpersonen
by: Jaehnert, Irene
Published: (2008)

Hämatologische Neoplasien in einem transgenen Mausmodell
by: Raffegerst, Silke
Published: (2007)

Experimentelle Prüfung neuer Strategien für die Therapie und Prophylaxe von Epilepsien
by: Fuest, Christina
Published: (2009)

Transcriptional effects of 177Lu-octreotate therapy using a priming treatment schedule on GOT1 tumor in nude mice
by: Johan Spetz, et al.
Published: (2019-03-01)

Necrosis binding of Ac-Lys0(IRDye800CW)-Tyr3-octreotate: a consequence from cyanine-labeling of small molecules
by: Marcus C. M. Stroet, et al.
Published: (2021-05-01)